Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 9.36
+0.30 (3.31%)
Last updated: Oct 21, 2026, 2:36 PM CEST
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 53.98 million as of October 21, 2026. It is the 28,255th most valuable company in the world and the 193rd biggest in Switzerland. Its market cap has decreased by 55.01% in one year.
Market Cap
53.98M
Enterprise Value
194.30M
Revenue
397.23K
Global Rank
Country Rank
#193 Switzerland
PE Ratio
n/a
ChartMarket Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 53.98M, a decrease of -77.55%. That is a compound annual growth rate of -27.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 53.98M | -62.11% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.31B |
| Idorsia | 1.15B |
| Basilea Pharmaceutica AG | 849.56M |
| Santhera Pharmaceuticals Holding AG | 226.77M |
| Newron Pharmaceuticals | 180.53M |
| BioVersys AG | 145.46M |
| Molecular Partners AG | 116.45M |
| MindMaze Therapeutics Holding | 26.25M |